Click here for an archive of Cramer's "Mad Money" Recaps.


Editor's note: The following is a wrap-up of "Mad Money" that originally aired on June 30. The show was rebroadcast Wednesday evening.

Jim Cramer laid out strategies for profiting in the stock market on aging Baby Boomers on CNBC's "Mad Money." He recommended shares of companies that develop drugs for hypertension, lasers for surgery and orthopedic implants, and discussed possible plays in assisted living, casinos and insurance.

In the drug sector, Cramer mentioned companies that, while not currently his favorites, might show promise over three to five years because of treatments for hypertension, impotence and osteoporosis. For hypertension, he mentioned GlaxoSmithKline ( GSK), Bristol-Myers ( BMY), Pfizer ( PFE), Eli Lilly ( LLY) and Merck ( MRK).

"The Boomer market for hypertension drugs hasn't even begun to blossom," Cramer said, adding that he had no favorite pick in the class. "It really could be any of the big pharmaceutical companies. So do what I do when I look at drugs: count prescriptions."

For erectile dysfunction, Cramer suggested considering Pfizer, Lilly and Glaxo, and mentioned several of the above stocks as possible plays on osteoporosis.

For cholesterol, Cramer praised Schering-Plough ( SGP), which sells Vytorin, saying the stock "makes a lot of sense" around $20.

In response to a caller's question, Cramer acknowledged that hospitals are gaining pricing power over drug companies, but said that alone doesn't make the stocks buys.

"There are other considerations, government, labor, and that makes it so HCA ( HCA) is too difficult to recommend."

Cramer felt similarly about generic-drug makers, saying: "I have found over and over again that margins can be cut to shreds to when too many companies can come in and make the same products. Triple sell, I think those stocks are dangerous."

To capitalize on Boomer vanity, Cramer urged viewers to consider companies that make lasers for cosmetic surgery, specifically Syneron ( ELOS), Cutera ( CUTR - Get Report) and Laserscope ( LSCP).

"These three companies pretty much have the market cornered right now," Cramer said, although he warned that they are "all little companies that could be displaced in moments by a bigger player."

Cramer also highlighted Patterson Dental ( PDCO - Get Report) and Dentsply ( XRAY - Get Report) as dental plays. "There will be ups and own in these stocks but the bottom line is they're pure plays on teeth and I have to tell you, unless you start growing a third set, you're going to need them."

For old-fashioned cosmetics, his picks were Procter & Gamble ( PG - Get Report) and Alberto-Culver ( ACV - Get Report), calling the latter "the pure hair-color play." He would buy Alberto-Culver before Avon ( AVP) or Revlon ( REV).

Responding to a caller, Cramer said Whole Foods ( WFMI) qualifies as a Boomer play because its wares help prevent disease. "While it's not a pure play on Baby Boomers I think it works and works large."

Cramer was long-term bullish on orthopedic implant makers Zimmer ( ZMH), Stryker ( SYK - Get Report) and Biomet ( BMET).

"I'm not incredibly enthusiastic about the sector in the near term, but you cannot argue with the huge market that's going to be created by 78 million Baby Boomers for orthopedic devices," he said. While the "long-term picture is strictly back up the truck," Cramer advised viewers to "let the pricing come down then pick among the rubble."

Cramer said higher-end assisted living companies like Sunrise Senior Living ( SRZ) could be winners as the population ages. He preferred Sunrise to Beverly Enterprises ( BEV), which is too dependent on the government.

Because its customers are wealthy, Sunrise "can't be brought low by big government deciding to cut Medicare/Medicaid. It's also less likely that Sunrise will have quality problems because of the big bucks laid down by its wealthy clients."

Cramer said Baby Boomers will want to gamble and mentioned Harrah's ( HET) and MGM Mirage ( MGM) as possible ways to profit. He also praised Royal Caribbean ( RCL - Get Report) and Carnival ( CCL) as cruise plays.

"This stuff can also change pretty rapidly," he said. "Stay abreast of where the Boomers are moving and what they're doing on their vacations by watching your friends."

Among insurers, Cramer spoke well of MetLife ( MET), Prudential ( PRU) and Manulife ( MFC) and said Nationwide Financial Services ( NFS), Lincoln National ( LNC) and Jefferson Pilot ( JP) have interesting lines.

But Cramer reiterated that his favorite insurance stock is UnitedHealth ( UNH - Get Report), which he said is "uniquely poised to capture the Baby Boomer market from every angle."

1. Pigs Get Slaughtered 2. It's OK to Pay the Taxes
3. Don't Buy All at Once 4. Buy Damaged Stocks
5. Diversify to Control Risk 6. Do Your Homework
7. Don't Panic 8. Buy Best-of-Breed
9. Defend Some Stocks 10. Don't Bet on Bad Stocks
11. Own Fewer Names 12. Cash Is for Winners
13. No Regrets 14. Expect Corrections
15. Know Bonds 16. Don't Subsidize Losers
17. No Room for Hope 18. Be Flexible
19. Quit When Execs Do 20. Patience Is a Virtue
21. Be a TV Critic 22. When to Wait 30 Days
23. Beware the Hype 24. Explain Your Picks
25. Find the Bull Market

At the time of publication, Cramer was long UnitedHealth Group.

James J. Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for ActionAlertsPLUS. While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by clicking here. Listen to Cramer's RealMoney Radio show on your computer; just click here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click here to get his second book, "You Got Screwed!" and click here to order Cramer's autobiography, "Confessions of a Street Addict."